Chemesis International Inc. (CSE:CSI, OTC:CADMF, FRA:CWAA) (the “Company” or “Chemesis”), announces that its subsidiary, GSRX Industries Inc. (“GSRX”) (OTCQB:GSRX), filed its interim financial statements for the six months ended June 30, 2019 (“GSRX Financial Statements”). […]

PreveCeutical Medical Inc. (CSE:PREV, OTCQB: PRVCF, FSE:18H) (the “Company” or “PreveCeutical”), is pleased to provide an update on its dual gene therapy program, an important and fundamental aspect of which involves the design, synthesis and screening […]

Osoyoos Cannabis Inc. (CSE:OSO) (“Osoyoos” or the “Company”) announces that it has entered into a debt settlement agreement with an arm’s length creditor. The agreement reduces the Company’s liabilities by $750,000 and improves the Company’s […]